Medical AI's reliability problem just gained a powerful new testing ground. When artificial intelligence models analyze medical scans to identify organ boundaries or tumors, they often display dangerous overconfidence in ambiguous cases—potentially misleading doctors about cancer risks or treatment decisions. The newly released CURVAS dataset from University Hospital Erlangen provides researchers with a crucial benchmark to address this critical flaw in medical imaging algorithms. The dataset comprises 90 contrast-enhanced CT scans featuring pancreas, liver, and kidney segmentations, with each scan independently annotated by three medical experts. This multi-rater approach captures the natural variability that exists even among skilled radiologists when defining organ boundaries—a reality that current AI systems poorly handle. Rather than forcing consensus, the dataset preserves disagreements between experts, creating a more realistic testing environment for uncertainty quantification algorithms. The resource enables researchers to develop AI models that not only segment organs accurately but also communicate their confidence levels appropriately to clinicians. This calibration aspect proves essential because overconfident AI predictions can skew medical decision-making, potentially causing doctors to overestimate or underestimate malignancy risks. The dataset's focus on volumetric organ assessment adds practical clinical value, as organ volume measurements directly inform treatment planning and disease monitoring. By providing standardized benchmarks for segmentation accuracy, uncertainty estimation, and calibration quality simultaneously, this resource addresses a fundamental challenge in medical AI deployment. The initiative represents a shift toward developing more clinically responsible AI systems that acknowledge their limitations rather than projecting false certainty in ambiguous diagnostic scenarios.